Business Description
Rapid Dose Therapeutics Corp
NAICS : 325412
SIC : 3741
ISIN : CA75339A1012
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -2.19 | |||||
Debt-to-Equity | -0.69 | |||||
Debt-to-EBITDA | -0.66 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -40.04 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -30.7 | |||||
3-Year EPS without NRI Growth Rate | -20.5 | |||||
3-Year FCF Growth Rate | -1.6 | |||||
3-Year Book Growth Rate | -24.5 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.9 | |||||
9-Day RSI | 59.42 | |||||
14-Day RSI | 58.05 | |||||
6-1 Month Momentum % | 28.91 | |||||
12-1 Month Momentum % | 1101.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.21 | |||||
Quick Ratio | 0.15 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 103.71 | |||||
Days Sales Outstanding | 27.8 | |||||
Days Payable | 1455.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.5 | |||||
Shareholder Yield % | -5.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.03 | |||||
Operating Margin % | -288.45 | |||||
Net Margin % | -401.86 | |||||
FCF Margin % | -212.7 | |||||
ROA % | -283.6 | |||||
ROIC % | -214.89 | |||||
ROC (Joel Greenblatt) % | -350.63 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 21.82 | |||||
EV-to-EBIT | -7.48 | |||||
EV-to-EBITDA | -8.41 | |||||
EV-to-Revenue | 24.75 | |||||
EV-to-FCF | -11.67 | |||||
Earnings Yield (Greenblatt) % | -13.37 | |||||
FCF Yield % | -9.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RDTCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rapid Dose Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.984 | ||
EPS (TTM) ($) | -0.028 | ||
Beta | 18.89 | ||
Volatility % | 4620.73 | ||
14-Day RSI | 58.05 | ||
14-Day ATR ($) | 0.004087 | ||
20-Day SMA ($) | 0.17365 | ||
12-1 Month Momentum % | 1101.99 | ||
52-Week Range ($) | 0.0029 - 0.39 | ||
Shares Outstanding (Mil) | 127.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rapid Dose Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rapid Dose Therapeutics Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Rapid Dose Therapeutics Corp Frequently Asked Questions
What is Rapid Dose Therapeutics Corp(RDTCF)'s stock price today?
When is next earnings date of Rapid Dose Therapeutics Corp(RDTCF)?
Does Rapid Dose Therapeutics Corp(RDTCF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |